Overview


According to FutureWise analysis the market for Amniocentesis Needle is expected to register a CAGR of 2.80% from 2023-2031.

An amniocentesis needle is a specialized medical instrument used in a diagnostic procedure called amniocentesis. Amniocentesis is a prenatal test performed during pregnancy to acquire a sample of the amniotic fluid that surrounds the fetus in the uterus. This fluid contains fetal cells and various substances that can provide valuable information about the health and development of the baby. The amniocentesis procedure involves inserting a thin and hollow needle through the mother's abdominal wall and into the amniotic sac, where the fetus is surrounded by amniotic fluid. The purpose of the procedure is to extract a small amount of amniotic fluid for testing. This fluid is then analysed in a laboratory to gather information about the foetus’s genetic makeup, chromosomal abnormalities, and potential health issues.

The amniocentesis needle is carefully designed to minimize discomfort and risk to both the mother and the foetus. It is typically long and thin, with a sharp tip that facilitates precise insertion through the abdominal wall. The needle is guided into a specific location within the amniotic sac under the guidance of ultrasound imaging, ensuring the safety of the procedure. Once in position, a small amount of amniotic fluid is gently drawn into a syringe attached to the needle. The needle is then removed, and the collected fluid is issued to a laboratory for testing. Amniocentesis is often recommended for pregnant women who may have an increased risk of certain genetic conditions, chromosomal abnormalities, or birth defects. The information obtained from the amniotic fluid can help healthcare professionals make brief decisions about the management of the pregnancy and provide expectant parents with a better understanding of their baby's health.

FutureWise Market Research has published a report that provides an insightful analysis of Amniocentesis Needle Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the Amniocentesis Needle Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Medtronic
  • Becton, Dickinson and Company
  • Coopersurgical
  • Integra Lifesciences
  • Smiths Medical
  • Medline
  • Cook Medical
  • Laboratoire Ccd
  • Biopsybell
  • Ri.Mos.
  • Tsunami Medical
  • Rocket Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

The amniocentesis needles market is anticipated to exhibit steady growth throughout the forecast period. Several factors contribute to this growth trajectory, including the rising median age of first-time motherhood, an increasing burden of congenital diseases, and the high level of reliability associated with amniocentesis procedures. Amniocentesis is renowned for its exceptional accuracy, with a success rate of approximately 99.4%. This diagnostic test serves as a crucial tool for assessing the presence of genetic or chromosomal abnormalities in foetuses. It holds the capability to identify a range of genetic disorders such as Down syndrome, Edward's syndrome, Tay-Sachs disease, Huntington's disease, sickle cell disease, and cystic fibrosis. By offering insights into these potential complications, amniocentesis plays a pivotal role in facilitating early diagnosis and informed decision-making for expectant parents. Given the high reliability of this test, its widespread adoption across various healthcare facilities fuels its demand and contributes to the projected market expansion. Moreover, the growing concern surrounding genetic disorders significantly drives the increasing number of amniocentesis procedures. In-depth studies conducted by reputable organizations like the National Institute of Health (NIH) delve into understanding the associated risks and challenges of the amniocentesis procedure. One of the identified risks is the occurrence of early abortion following the procedure, with a prevalence rate of around 10%. Nevertheless, advancements in needle technology and the medical community's focus on patient safety are expected to mitigate the incidence of early abortions in the future. Also, the continuous enhancement of research and development capabilities, coupled with the ever-expanding pregnant population and improving personal disposable income, presents promising growth opportunities for the market. These factors collectively create an environment conducive to the adoption of advanced medical technologies and services, boosting market revenue. However, the high procedural cost associated with these medical advancements presents a potential obstacle to the market's growth rate. Affordability concerns could hinder patient access to these advanced treatments. Moreover, an unfavorable reimbursement landscape poses challenges, particularly in terms of patient coverage for procedures and therapies. In addition, the lack of awareness and resources in developing and underdeveloped economies creates hurdles to market penetration.

By Type

  • 100–150 mm
  • Larger than 150 mm
  • Smaller than 100 mm

By Procedure

  • Amniocentesis
  • Amnioreduction
  • Fetal Blood Transfusion
  • Amnioinfusion
  • Cordocentesis

By End User

  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022 owing to the robust government initiatives and a growing prevalence of amniocentesis procedures, collectively driving the expansion of the market within the region. The well-established healthcare infrastructure in the United States serves as a significant catalyst, fueling the demand for cutting-edge products in the field. This demand surge is particularly evident in the adoption of technologically advanced amniocentesis needles. The nation's commitment to staying at the forefront of medical advancements propels market growth, fostering the integration of state-of-the-art technology in amniocentesis procedures. Furthermore, the general population's heightened awareness and concern regarding genetic disorders in newborns contribute to the escalating demand for amniocentesis procedures. This growing consciousness is driving expectant parents to seek accurate and timely prenatal diagnostic solutions, resulting in increased utilization of amniocentesis and associated products.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Amniocentesis Needle Market By Type, By Procedure, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Amniocentesis Needle Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amniocentesis Needle Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Amniocentesis Needle Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Amniocentesis Needle Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 100–150 mm
        2. Larger than 150 mm
        3. Smaller than 100 mm

  • 8.   Global Amniocentesis Needle Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Amniocentesis
        2. Amnioreduction
        3. Fetal Blood Transfusion
        4. Amnioinfusion
        5. Cordocentesis

  • 9.   Global Amniocentesis Needle Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Centers
        3. Clinics
        4. Other End Users

  • 10.   North America Amniocentesis Needle Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Amniocentesis Needle Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Amniocentesis Needle Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         11.2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Amniocentesis Needle Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Becton, Dickinson and Company
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Coopersurgical
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Integra Lifesciences
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Smiths Medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Medline
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Siemens Healthcare Private Limited
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Laboratoire Ccd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Biopsybell
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Ri.Mos.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Tsunami Medical
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Rocket Medical
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients